Abeona’s gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12% – Seeking Alpha
|
Abeona’s gene therapy candidate for Sanfilippo B shows encouraging effect in first patient; shares up 12%
Seeking Alpha Abeona Therapeutics (ABEO +11.6%) is up on modestly higher volume in response to its announcement of encouraging data from the first MPS IIIB (Sanfilippo syndrome type B) patient treated with gene therapy candidate ABO-101. MPS IIIB … Abeona Therapeutics Reports on Initial Safety and Biopotency Signals in MPS IIIB Gene Therapy Clinical TrialGlobeNewswire (press release) Why Abeona Therapeutics Jumped 14% on WednesdayMotley Fool Maxim Group Assigns a Buy Rating on Abeona TherapeuticsAnalyst Ratings BZ Weekly –StockNewsTimes all 22 news articles » |
Forbes |
Why A Gene Therapy Pioneer Is Raising Concerns About Treatments He Championed
Forbes It’s a hard won expertise. In 1999, when it seemed that gene therapy was on the cusp of becoming a reality, a patient in a study Wilson was running died. The memory of that young man, 18-year-old Jesse Gelsinger, has motivated him to find better … |
gulfnews.com |
Stem cell therapy way forward for joint issues
gulfnews.com Regenerative healing therapy seems to be the way forward in the treatment of arthritis and other joint and knee issues. The ground-breaking treatment will exponentially reduce a person’s need for surgery. Instead of having to replace a knee with an … |